1. Signaling Pathways
  2. Metabolic Enzyme/Protease
  3. Apolipoprotein
  4. Apolipoprotein Control

Apolipoprotein Control

Apolipoprotein Controls (2):

Cat. No. Product Name Effect Purity
  • HY-147425C
    Zerlasiran sodium scrambled negative control
    Control
    Zerlasiran (SLN360) sodium scrambled negative control is the sequence scrambled negative control of Zerlasiran sodium (HY-147425A). Zerlasiran sodium is a siRNA targeting apolipoprotein A (ApoA). Zerlasiran sodium targets hepatic ApoA synthesis via RNA interference to degrade encoding mRNA. Zerlasiran sodium can be used for the research of atherosclerotic cardiovascular disease and elevated ApoA levels.
  • HY-145727C
    Volanesorsen scramble negative control
    Control 98.82%
    Volanesorsen scramble negative control is a negative control for volanesorsen (HY-145727) with the sequence: CAUGUTCUTCUGCATGUCAU. Volanesorsen (ISIS 304801) is an antisense oligonucleotide inhibitor of apolipoprotein CIII (apo-CIII) mRNA that can lower triglyceride levels and improve insulin resistance.